These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33129902)

  • 41. The Ile-84-->Ser amino acid substitution in transthyretin interferes with the interaction with plasma retinol-binding protein.
    Berni R; Malpeli G; Folli C; Murrell JR; Liepnieks JJ; Benson MD
    J Biol Chem; 1994 Sep; 269(38):23395-8. PubMed ID: 8089102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin.
    Higaki JN; Chakrabartty A; Galant NJ; Hadley KC; Hammerson B; Nijjar T; Torres R; Tapia JR; Salmans J; Barbour R; Tam SJ; Flanagan K; Zago W; Kinney GG
    Amyloid; 2016 Jun; 23(2):86-97. PubMed ID: 26981744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Uncovering the Mechanism of Aggregation of Human Transthyretin.
    Saelices L; Johnson LM; Liang WY; Sawaya MR; Cascio D; Ruchala P; Whitelegge J; Jiang L; Riek R; Eisenberg DS
    J Biol Chem; 2015 Nov; 290(48):28932-43. PubMed ID: 26459562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured.
    Jiang X; Smith CS; Petrassi HM; Hammarström P; White JT; Sacchettini JC; Kelly JW
    Biochemistry; 2001 Sep; 40(38):11442-52. PubMed ID: 11560492
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of V30A mutation on transthyretin protein structural stability and cytotoxicity against neuroblastoma cells.
    Zhang F; Hu C; Dong Y; Lin MS; Liu J; Jiang X; Ge Y; Guo Y
    Arch Biochem Biophys; 2013 Jul; 535(2):120-7. PubMed ID: 23523753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thermodynamic stability and denaturation kinetics of a benign natural transthyretin mutant identified in a Danish kindred.
    Groenning M; Campos RI; Fagerberg C; Rasmussen AA; Eriksen UH; Powers ET; Hammarström P
    Amyloid; 2011 Jun; 18(2):35-46. PubMed ID: 21406045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro.
    Cascella R; Conti S; Mannini B; Li X; Buxbaum JN; Tiribilli B; Chiti F; Cecchi C
    Biochim Biophys Acta; 2013 Dec; 1832(12):2302-14. PubMed ID: 24075940
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma retinol-binding protein: structure and interactions with retinol, retinoids, and transthyretin.
    Zanotti G; Berni R
    Vitam Horm; 2004; 69():271-95. PubMed ID: 15196886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. S-Homocysteinylation effects on transthyretin: worsening of cardiomyopathy onset.
    Leri M; Rebuzzini P; Caselli A; Luti S; Natalello A; Giorgetti S; Marchese L; Garagna S; Stefani M; Paoli P; Bucciantini M
    Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129453. PubMed ID: 31676294
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: implications in vitamin A homeostasis and transthyretin amyloidosis.
    Raghu P; Sivakumar B
    Biochim Biophys Acta; 2004 Dec; 1703(1):1-9. PubMed ID: 15588697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amyloid disease prevention by transthyretin native state complexation with carborane derivatives lacking cyclooxygenase inhibition.
    Julius RL; Hawthorne MF
    Drug News Perspect; 2008 Jun; 21(5):258-66. PubMed ID: 18596990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of the glutamic acid 54 residue in transthyretin stability and thyroxine binding.
    Miyata M; Sato T; Mizuguchi M; Nakamura T; Ikemizu S; Nabeshima Y; Susuki S; Suwa Y; Morioka H; Ando Y; Suico MA; Shuto T; Koga T; Yamagata Y; Kai H
    Biochemistry; 2010 Jan; 49(1):114-23. PubMed ID: 19950966
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conformational differences between the wild type and V30M mutant transthyretin modulate its binding to genistein: implications to tetramer stability and ligand-binding.
    Trivella DB; Bleicher L; Palmieri Lde C; Wiggers HJ; Montanari CA; Kelly JW; Lima LM; Foguel D; Polikarpov I
    J Struct Biol; 2010 Jun; 170(3):522-31. PubMed ID: 20211733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human TTR conformation altered by rhenium tris-carbonyl derivatives.
    Ciccone L; Policar C; Stura EA; Shepard W
    J Struct Biol; 2016 Sep; 195(3):353-364. PubMed ID: 27402536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural and dynamics evidence for scaffold asymmetric flexibility of the human transthyretin tetramer.
    Zanotti G; Vallese F; Ferrari A; Menozzi I; Saldaño TE; Berto P; Fernandez-Alberti S; Berni R
    PLoS One; 2017; 12(12):e0187716. PubMed ID: 29240759
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The tetrameric protein transthyretin dissociates to a non-native monomer in solution. A novel model for amyloidogenesis.
    Quintas A; Saraiva MJ; Brito RM
    J Biol Chem; 1999 Nov; 274(46):32943-9. PubMed ID: 10551861
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH.
    Ueda M; Okada M; Mizuguchi M; Kluve-Beckerman B; Kanenawa K; Isoguchi A; Misumi Y; Tasaki M; Ueda A; Kanai A; Sasaki R; Masuda T; Inoue Y; Nomura T; Shinriki S; Shuto T; Kai H; Yamashita T; Matsui H; Benson MD; Ando Y
    J Biol Chem; 2019 Jul; 294(29):11259-11275. PubMed ID: 31167790
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Initial conformational changes of human transthyretin under partially denaturing conditions.
    Yang M; Lei M; Bruschweiler R; Huo S
    Biophys J; 2005 Jul; 89(1):433-43. PubMed ID: 15821170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endoplasmic Reticulum Proteostasis Influences the Oligomeric State of an Amyloidogenic Protein Secreted from Mammalian Cells.
    Chen JJ; Genereux JC; Suh EH; Vartabedian VF; Rius B; Qu S; Dendle MTA; Kelly JW; Wiseman RL
    Cell Chem Biol; 2016 Oct; 23(10):1282-1293. PubMed ID: 27720586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transthyretin forms amyloid fibrils at physiological pH with ultrasonication.
    Misumi Y; Ueda M; Fujimori H; Shinriki S; Meng W; Kim J; Saito S; Obayashi K; Uchino M; Ando Y
    Amyloid; 2008 Dec; 15(4):234-9. PubMed ID: 19065294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.